InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
2
T+90 hit rate
44%
T+90 mean return
-2.9%
Across 9 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Moreland Mary K, Chairman & CEO. Insider active across 1 company, notably Abbott Laboratories. In total, 14 disclosures have been published. Breakdown: 0 buy · 2 sells. Total volume traded: €165k. History available since 1 August 2021. The latest transaction was filed on 2 March 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations14 total
4,630 shares@ US$116.2613.4% of flowCommon shares without par valueSEC:0001783147-26-000007:0
613 shares@ US$115.581.8% of flowCommon shares without par valueSEC:0001783147-26-000007:1
5,598 shares@ US$135.8721.5% of flowCommon shares without par valueSEC:0001415889-25-006786:0
791 shares@ US$138.173.1% of flowCommon shares without par valueSEC:0001415889-25-006786:1
10,712 shares0Common shares without par valueSEC:0001415889-25-005897:0
5,862 shares@ US$120.0519.1% of flowCommon shares without par valueSEC:0001415889-24-006410:0
10,574 shares0Common shares without par valueSEC:0001415889-24-005105:0
5,926 shares@ US$99.7716.4% of flowCommon shares without par valueSEC:0001415889-23-003912:0
12,259 shares0Common shares without par valueSEC:0001415889-23-003057:0
1,245 shares@ US$108.843.9% of flowCommon shares without par valueSEC:0001415889-22-008158:0
4,112 shares@ US$122.410.0002% mcap63.9% of flowCommon shares without par valueSEC:0001415889-22-002197:0
15,813 shares0Common shares without par valueSEC:0001415889-22-001742:0
1,245 shares@ US$120.980.0001% mcap18.0% of flowCommon shares without par valueSEC:0001415889-21-003773:0
1,245 shares@ US$120.983.7% of flowCommon shares without par valueSEC:0001415889-21-003773
14 of 14 declarations
About Moreland Mary K
Mary K Moreland is the President and CEO of Abbott Laboratories. She oversees the company's overall operations, which is a global leader in healthcare. Mary K Moreland is responsible for implementing the company's growth strategy and innovation in products and services. Her leadership is essential for maintaining Abbott's market position and meeting customer needs.
